Yantai Zhenghai Biotechnology Co., Ltd.

SZSE:300653 Stock Report

Market Cap: CN¥3.9b

Yantai Zhenghai Biotechnology Past Earnings Performance

Past criteria checks 3/6

Yantai Zhenghai Biotechnology has been growing earnings at an average annual rate of 15.4%, while the Biotechs industry saw earnings growing at 5.4% annually. Revenues have been growing at an average rate of 12.3% per year. Yantai Zhenghai Biotechnology's return on equity is 18%, and it has net margins of 45.1%.

Key information

15.4%

Earnings growth rate

18.4%

EPS growth rate

Biotechs Industry Growth11.3%
Revenue growth rate12.3%
Return on equity18.0%
Net Margin45.1%
Next Earnings Update06 Aug 2024

Recent past performance updates

Recent updates

Yantai Zhenghai Biotechnology Co., Ltd. (SZSE:300653) Held Back By Insufficient Growth Even After Shares Climb 26%

Mar 04
Yantai Zhenghai Biotechnology Co., Ltd. (SZSE:300653) Held Back By Insufficient Growth Even After Shares Climb 26%

Revenue & Expenses Breakdown

How Yantai Zhenghai Biotechnology makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

SZSE:300653 Revenue, expenses and earnings (CNY Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Mar 2439417812840
31 Dec 2341419113244
30 Sep 2341417814044
30 Jun 2342619114044
31 Mar 2342518414142
01 Jan 2343318514638
30 Sep 2244019715039
30 Jun 2243119214738
31 Mar 2241618014936
31 Dec 2140016915235
30 Sep 2137814915732
30 Jun 2136014414830
31 Mar 2135114314429
31 Dec 2029311812627
30 Sep 2029512312224
30 Jun 2028211112622
31 Mar 2026310012622
31 Dec 1928010713121
30 Sep 1925110011919
30 Jun 192439711418
31 Mar 192309110718
31 Dec 182168610017
30 Sep 18216889617
30 Jun 18204818725
31 Mar 18193768819
31 Dec 17183629516
30 Sep 171765410012
30 Jun 17164471060
31 Mar 17159461020
31 Dec 1615145950
30 Jun 1613843890
31 Mar 1612641810
31 Dec 1512842800
31 Dec 1410534650
31 Dec 137716520

Quality Earnings: 300653 has high quality earnings.

Growing Profit Margin: 300653's current net profit margins (45.1%) are higher than last year (43.3%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 300653's earnings have grown by 15.4% per year over the past 5 years.

Accelerating Growth: 300653's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: 300653 had negative earnings growth (-3.2%) over the past year, making it difficult to compare to the Biotechs industry average (-3.2%).


Return on Equity

High ROE: 300653's Return on Equity (18%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.